Citius Pharmaceuticals, Inc.

CTXR · Nasdaq · SIC 2834: Pharmaceutical Preparations
305
SEC Filings

Business Summary

PART I Overview Citius Pharmaceuticals, Inc., headquartered in Cranford, New Jersey, is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and unique prescription products. Our goal generally is to achieve leading market positions by providing therapeutic products that address unmet medical needs yet have a lower development risk than usually is associated with n...

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCTXRdiscussed_in_filing Artificial Intelligence
topic_mentionCTXRdiscussed_in_filing Cybersecurity
topic_mentionCTXRdiscussed_in_filing Trusted Computing
topic_mentionCTXRdiscussed_in_filing Blockchain & Crypto
topic_mentionCTXRdiscussed_in_filing Regulation
topic_mentionCTXRdiscussed_in_filing Healthcare & Bio
topic_mentionCTXRdiscussed_in_filing Sovereign & Government
topic_mentionCTXRdiscussed_in_filing Artificial Intelligence
topic_mentionCTXRdiscussed_in_filing Cybersecurity
topic_mentionCTXRdiscussed_in_filing Trusted Computing
topic_mentionCTXRdiscussed_in_filing Blockchain & Crypto
topic_mentionCTXRdiscussed_in_filing Regulation
topic_mentionCTXRdiscussed_in_filing Healthcare & Bio
topic_mentionCTXRdiscussed_in_filing Sovereign & Government
topic_mentionCTXRdiscussed_in_filing Artificial Intelligence
topic_mentionCTXRdiscussed_in_filing Cybersecurity
topic_mentionCTXRdiscussed_in_filing Trusted Computing
topic_mentionCTXRdiscussed_in_filing Blockchain & Crypto
topic_mentionCTXRdiscussed_in_filing Regulation
topic_mentionCTXRdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-12-232025-09-300001213900-25-125333EDGAR76K words
2024-12-272024-09-300001213900-24-113149EDGAR—
2023-12-292023-09-300001213900-23-099889EDGAR—
2022-12-222022-09-300001213900-22-082217EDGAR—
2021-12-152021-09-300001213900-21-065464EDGAR—
2020-12-162020-09-300001213900-20-043004EDGAR—
2019-12-162019-09-300001213900-19-026259EDGAR—
2018-12-112018-09-300001213900-18-017214EDGAR—
2017-12-132017-09-300001213900-17-013191EDGAR—
2016-12-232016-09-300001477932-16-014315EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-132025-12-310001213900-26-015878EDGAR21K words
2025-08-122025-06-300001213900-25-074997EDGAR—
2025-05-142025-03-310001213900-25-043360EDGAR—
2025-02-142024-12-310001213900-25-014321EDGAR—
2024-08-122024-06-300001213900-24-067732EDGAR—
2024-05-142024-03-310001213900-24-042920EDGAR—
2024-02-142023-12-310001213900-24-014096EDGAR—
2023-08-142023-06-300001213900-23-067024EDGAR—
2023-05-122023-03-310001213900-23-039031EDGAR—
2023-02-102022-12-310001213900-23-010315EDGAR—
2022-08-112022-06-300001213900-22-046897EDGAR—
2022-05-122022-03-310001213900-22-025975EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-060001213900-26-040474EDGAR1K words
2026-03-310001213900-26-037524EDGAR—
2026-03-100001213900-26-025459EDGAR—
2026-03-040001213900-26-023439EDGAR—
2026-02-130001213900-26-015895EDGAR—
2025-12-230001213900-25-125413EDGAR—
2025-12-010001213900-25-116760EDGAR—
2025-10-230001213900-25-101741EDGAR—
2025-10-210001213900-25-100847EDGAR—
2025-08-120001213900-25-075034EDGAR—

305 total filings indexed. 273 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001506251
TickerCTXR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b48497bfcc781b677cab4b0924b6312a20a64e90b45795bc58928421c2e671a2
parent: 0d96c1717df6c6eeb4b9e6288a3c4650f0073967b31442029b6c7271a4120a30
content hash: f85f5ca772fec9156ba751bdb702236a7050931c82f0ad8c75585c3fd9379219
signed: 2026-04-13T04:44:32.995Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf